Adverum Biotechnologies Inc (ADVM) — Working Capital to Net Assets Ratio
Adverum Biotechnologies Inc (ADVM) has a Working Capital to Net Assets ratio of 28.5% as of September 2025. Working capital of $-15.84 Million (current assets of $28.91 Million minus current liabilities of $44.75 Million) is measured against net assets of $-55.65 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Adverum Biotechnologies Inc to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Adverum Biotechnologies Inc Working Capital to Net Assets (2012–2024)
This chart shows how Adverum Biotechnologies Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 28.5%, reflecting working capital of $-15.84 Million against net assets of $-55.65 Million USD. Check how tangible is Adverum Biotechnologies Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Adverum Biotechnologies Inc (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Adverum Biotechnologies Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Adverum Biotechnologies Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 153.3% | $108.40 Million | $70.71 Million | $131.30 Million | $22.90 Million | ▲ +30.1 pp |
| 2023 | 123.2% | $82.79 Million | $67.22 Million | $102.77 Million | $19.98 Million | ▲ +35.9 pp |
| 2022 | 87.2% | $158.35 Million | $181.52 Million | $190.59 Million | $32.25 Million | ▼ -6.3 pp |
| 2021 | 93.6% | $295.82 Million | $316.19 Million | $317.14 Million | $21.32 Million | ▼ -1.7 pp |
| 2020 | 95.2% | $413.57 Million | $434.35 Million | $434.44 Million | $20.87 Million | ▲ +5.8 pp |
| 2019 | 89.4% | $156.46 Million | $174.96 Million | $175.87 Million | $19.41 Million | ▼ -9.0 pp |
| 2018 | 98.4% | $198.03 Million | $201.17 Million | $208.75 Million | $10.72 Million | ▼ -1.0 pp |
| 2017 | 99.5% | $183.07 Million | $184.03 Million | $193.74 Million | $10.67 Million | ▼ -0.4 pp |
| 2016 | 99.9% | $215.38 Million | $215.60 Million | $225.27 Million | $9.90 Million | ▼ -0.8 pp |
| 2015 | 100.7% | $254.42 Million | $252.59 Million | $260.99 Million | $6.57 Million | ▼ -2.8 pp |
| 2014 | 103.6% | $154.81 Million | $149.48 Million | $160.28 Million | $5.47 Million | ▼ -52.4 pp |
| 2013 | 156.0% | $-340.00K | $-218.00K | $822.00K | $1.16 Million | ▲ +110.1 pp |
| 2012 | 45.8% | $-457.00K | $-997.00K | $382.00K | $839.00K | — |